01 · ABSTRACT
Abstract
Breast cancer has a complex biology, but in this complexity,for optimal treatment , it needs to find the precise situation of a specific drugs which even in routine practice can not increase survival of the patients and ,antiangiogenesis medicine is an example;this review is a reminder that for this heterogenous disease, challenges persistently is present to use for correct timing of antiangiogenesis treatment.
↓ Read PDF02 · OJS METADATA
Keywords
breast cancerantiangiogenesismetastasisVEGF and VEGFR system
03 · PUBLICATION RECORD
Article details
JournalMedical Research Archives
IssueVol 5 No 2 (2017): Vol.5 Issue 2, February, 2017
SectionResearch Articles
Published15 February 2017
ISSN2375-1924
04 · RIGHTS & REUSE
Rights & reuse
This article is published under a Creative Commons Attribution License (CC BY 3.0) and may be shared or distributed by anyone as long as attribution is given to the journal.